Previous
Next

Country/Region

June 03, 2016

Following an outbreak of yellow fever in Angola this past December and the subsequent confirmation of dozens of cases in the Democratic Republic of Congo (DRC), Doctors Without Borders/Médecins Sans Frontières (MSF) teams are providing support in both countries to help contain the spread of the disease.

October 24, 2014

Following a high level meeting on access and funding for Ebola vaccines convened yesterday by World Health Organization (WHO), Médecins Sans Frontières/Doctors Without Borders (MSF) has urged that plans to get forthcoming Ebola vaccines and treatments to frontline workers must be rapidly implemented. Significant investment and incentives are needed now to accelerate these steps.

MSF calls for health groups to get more involved

Zoe grew up and was educated in London and has worked both in the UK and abroad for a number of humanitarian organisations including Oxfam, Interact, and Médecins Sans Frontières (MSF). She is a water and sanitation expert with significant field experience in Rwanda, Kenya, the Democratic Republic of Congo, Sudan and Angola. In 2005, Zoe worked in Uige, Angola following an outbreak of deadly Marburg disease, which is a haemorrhagic fever similar to Ebola.

The international medical humanitarian organization Médecins Sans Frontières (MSF) denounces the pervasive and systematic use of rape and violence committed by the Angolan army during the expulsions of Congolese migrants working in diamond mines in the Angolan province of Lunda Norte. MSF teams arrived in Western Kasai — a Congolese province bordering Angola — in October 2007 and are providing care there to victims of sexual violence. They have also collected 100 testimonies exposing collective rape and physical abuse widely perpetrated by the Angolan military.

Since May 26, more than 30,000 Congolese expelled from Angola have crossed the border at Kahungula, Bandundu province, in the southwest of the Democratic Republic of Congo (DRC). In response to an alert sounded by the Congolese authorities, MSF went to the area to provide healthcare and to assess the situation of the expelled people. MSF offered medical assistance to the 600 to 700 Congolese being expelled daily and collected their testimonies.

The medical humanitarian organization Médecins Sans Frontières (MSF) is shocked by the judgment rendered by Switzerland's highest judicial body, the Federal Tribunal. Following four years of proceedings, and in spite of two previous rulings in favour of MSF, the Federal Tribunal partly ruled in favour of the Dutch state by ruling that the financial burden should be shared between the two parties. This decision sets a grave precedent for independent humanitarian action in zones of conflict.

Thousands of displaced people have been streaming into the Ariwara area, near Aru, in the northeast of Democratic Republic of Congo (DRC) for several weeks. They’ve been fleeing other parts of neighbouring Haut-Uélé where the Lord’s Resistance Army (LRA) has continued its attacks. MSF project coordinator Patrick Robitaille bears witness to the MSF’s team’s concerns about chronic insecurity and the resulting malnutrition and sanitation problems.

The Executive Board of UNITAID, the international health financing agency, will meet Dec. 14-15 in Geneva to decide on the future direction of the Patent Pool for AIDS medicines. International medical humanitarian organization Médecins Sans Frontières (MSF) is concerned that a number of pharmaceutical companies are seeking to exclude developing countries categorized as ‘middle-income’ from benefiting from medicines made under licence from the Pool.  If these companies are successful, people living with HIV/AIDS will be made to pay the price.

In a decisive step to improve access to medicines in the developing world, the Executive Board of UNITAID, the international health financing agency, has given the green light for a patent pool for HIV/AIDS medicines to open for business. “Although these are early days, the patent pool could become a mechanism that systematically offers licenses to generic manufacturers, reducing prices and facilitating the combination of drugs from different makers into fixed-dose or one pill combinations,” said Dr.